Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P14 - Immunotherapy (Phase II/III Trials) - Clinical Trial in Progress
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 7
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P14.03 - Vibostolimab Plus Pembrolizumab With/Without Docetaxel vs Docetaxel in NSCLC After Platinum Chemotherapy and Immunotherapy
00:00 - 00:00 | Presenter: Solange Peters
- Abstract
Loading...
-
+
P60 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Other Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 14
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P60.12 - Prevalence of c-Met overexpression (c-Met+) and Impact of Prior Lines of Treatment on c-Met Protein Expression in NSCLC
00:00 - 00:00 | Presenter: Monica Motwani
- Abstract
Loading...
-
+
ES04 - Antibody–Drug Conjugates: Current Status and Future Perspectives*
- Type: Education Session
- Track: Novel Therapeutics and Targeted Therapies
- Presentations: 5
*Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.- Moderators:Maria Rosario García Campelo
- Coordinates: 9/10/2021, 09:00 - 09:35, Program Auditorium
-
+
ES04.03 - Antibody Drug Conjugates for Other Thoracic Tumor Types
09:04 - 09:06 | Presenter: David Planchard
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.